Openbookopenbook
Equity
Bachem Holding AG(BCHMY)
USD --+0.00%
Reward48Moderate
Risk37Moderate
📊75%Data
Strong 21% profit margin · 9.6% dividend yield
BCHMY
+0.0 · +0.00%
USD · PINK
Bachem Holding AG | Basic Materials
Dividend King
Market Cap:6.67Bn
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
37
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BCHMY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Bachem Holding AG?

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

BCHMY · Verdict

Moderate reward · moderate risk

BCHMY stands out on cash flow and growth, but watch the valuation signal.

Based on 88% data coverage

BCHMY · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow71/100

    -8% free-cash-flow margin

  • Growth65/100

    Rev +9.3% CAGR · earnings +13.9%

  • Volatility65/100

    Above average

Watchouts 2

  • Valuation13/100

    P/E 28.7×

  • Profitability41/100

    21% net margin · 10% ROE

Model-based scoring. For information only — not financial advice.

What is Bachem Holding AG?

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company is listed on the PINK in USA, operating in the Basic Materials sector, with a market capitalisation of 6.67B, and a P/E ratio of 35.6x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorBasic Materials
Market Cap6.67B
P/E Ratio35.6
Dividend Yield9.56%
52 Week High9.98
52 Week Low6.1
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding749M
No. of Employees2,130
IndustryChemicals
ExchangePINK
Beta0.785
CurrencyUSD · Reports in CHF
Websitewww.bachem.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.